Activity of clarithromycin against Mycobacterium avium complex infection in beige mice - Wikidata - awgldk - TriplyDB

Activity of clarithromycin against Mycobacterium avium complex infection in beige mice

Activity of clarithromycin against Mycobacterium avium complex infection in beige mice

http://www.wikidata.org/entity/Q28327192

about

sameAs

Activities of poloxamer CRL-1072 against Mycobacterium avium in macrophage culture and in mice Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model Comparative activities of azithromycin and clarithromycin against Mycobacterium avium infection in beige mice Intermittent azithromycin for treatment of Mycobacterium avium infection in beige mice Mycobacterium avium strains resistant to clarithromycin and azithromycin Comparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complex Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy.Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.Activities of azithromycin and clarithromycin against nontuberculous mycobacteria in beige mice.Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin.Beige mouse model for Mycobacterium avium complex disease.Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse model Therapy of multidrug-resistant tuberculosis: lessons from studies with mice.In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium.Rifabutin: a review with emphasis on its role in the prevention of disseminated Mycobacterium avium complex infection.

P2860

Q28343754-416317C0-D3D3-47B4-8913-B76FE873D65B Q28368056-C6D1B0F2-4D00-4007-8BAB-AB3E775CC1AE Q28368450-7FDA8C46-AFB1-4B97-BC91-A9A91B92E182 Q28369086-B5B58C7A-1EEA-4DB9-8135-E2575250E808 Q28369131-76BF8724-D3B3-4297-B709-E99EA8B97964 Q28369301-C7304E99-CE70-42EF-90C1-707CACC0AF16 Q28369712-7AFDD53D-1196-414A-96DA-0DCF24EEA4DD Q28379176-ADD4FFB7-3F8C-4BF3-9CB3-8C75E2099108 Q28379202-2B444D3A-13B9-4D7A-99A5-6C94AE84752D Q28379322-1D3E8FAA-E960-48D1-937F-D7CB704FAB53 Q33691292-169F7E3B-1B40-4378-BCC6-03D6D8C4E9BE Q33754030-304026B2-7068-4716-99DB-36C11C33C1D6 Q35111440-37CD425B-D8BB-40F6-ADB5-6451BBB7E3B1 Q35116742-FB0F66E4-6BB8-44FD-A716-5063F93D9C1F Q35822868-910408EE-6065-4483-9E06-8BBD8E4342FE Q35899883-90CC0D97-A773-47DD-924A-3D2DBFC24D58 Q39779350-C23D6B34-ACD5-4E9F-AC80-4891520B8AE9 Q40588129-2E4EADF2-CFF0-46DE-9F13-D53B288C565E

P2860

Activity of clarithromycin against Mycobacterium avium complex infection in beige mice

http://www.wikidata.org/entity/Q28327192

description

1992 nî lūn-bûn

@nan

1992 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1992 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

name

Activity of clarithromycin against Mycobacterium avium complex infection in beige mice

@ast

Activity of clarithromycin against Mycobacterium avium complex infection in beige mice

@en

Activity of clarithromycin against Mycobacterium avium complex infection in beige mice

@nl

type

label

Activity of clarithromycin against Mycobacterium avium complex infection in beige mice

@ast

Activity of clarithromycin against Mycobacterium avium complex infection in beige mice

@en

Activity of clarithromycin against Mycobacterium avium complex infection in beige mice

@nl

prefLabel

Activity of clarithromycin against Mycobacterium avium complex infection in beige mice

@ast

Activity of clarithromycin against Mycobacterium avium complex infection in beige mice

@en

Activity of clarithromycin against Mycobacterium avium complex infection in beige mice

@nl

P1433

Q28327192-FB0675A3-04CB-44C3-802C-B1C94BEE382C

P1476

Q28327192-DEEBABFA-7E16-48E0-B506-242E87426FEE

P2093

Q28327192-236BD4DC-F257-4C30-A1D3-53E8EA30DF81

Q28327192-2B1D9B66-007C-4C5E-B0F8-4F5BC588ED4B

Q28327192-68523880-873B-4A45-BD5D-380F2C272533

P2860

Q28327192-0CCAC78A-BFA3-41C6-8C2C-8BD7BDE8B05F

Q28327192-2330E6F1-2086-4595-A73C-CC98A475CFC0

Q28327192-2755805C-BC0D-4A8F-8705-91DB30D01544

Q28327192-2E9E0ED4-64E1-4ADD-85C3-61244B7FEFED

Q28327192-5F52411D-39D1-4888-B583-AC401EC95616

Q28327192-699103C9-1973-4A90-9918-31C9F64ADEE0

Q28327192-7F7DC7C0-7A56-4EC0-BC51-E1E9B2CE1CCD

Q28327192-959B14CB-D51A-4602-9F1B-C78C1428DD5D

Q28327192-A7FF7C27-DA41-48DD-9E18-9CE551533404

Q28327192-AA1F4FAC-6769-4A50-BB97-0E90D1B7D23E

P304

Q28327192-7297530F-2644-461E-B6EC-2280272A10B2

P31

Q28327192-E9F6C55B-7AE9-4BC3-A70F-CD326607DF17

P356

Q28327192-462B6DE6-463B-4DA8-9D21-68217D2DB653

P407

Q28327192-C7965854-B0CE-42FA-AA9C-CBAE0C77927F

P433

Q28327192-FA7040CA-3DD0-4B7A-B08D-610C5A2AF55D

P478

Q28327192-858039B3-5DD7-4D11-8C9F-3CF561E73E06

P577

Q28327192-DB5F9AE6-F7E4-4F42-9EAA-B025D43EC178

P5875

Q28327192-09C3CA42-A410-40A5-8B1F-0A5B94513793

P698

Q28327192-C57A5D15-AC44-45B5-90B6-E5EC02D649D4

P932

Q28327192-76B56236-B93D-405E-A59F-DFB4BDE1348F

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Activity of clarithromycin against Mycobacterium avium complex infection in beige mice

@en

P2093

M H Cynamon

http://www.w3.org/2001/XMLSchema#string

M S DeStefano

http://www.w3.org/2001/XMLSchema#string

S P Klemens

http://www.w3.org/2001/XMLSchema#string

P2860

Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages

In vivo activities of newer rifamycin analogs against Mycobacterium avium infection

Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex

Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages

Comparative in-vitro activities of ten fluoroquinolones and fusidic acid against Mycobacterium spp

Liposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige mice

Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin

In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex

In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice

Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods.

P304

2413-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.36.11.2413

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

1992-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21818655

http://www.w3.org/2001/XMLSchema#string

P698

1336945

http://www.w3.org/2001/XMLSchema#string

P932

284345

http://www.w3.org/2001/XMLSchema#string